The Paris system classification for urinary cytology in patients under bacillus Calmette‐Guerin treatment
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24952
Abstract: The role of urinary cytology as a diagnostic test for the detection and surveillance of urothelial cancer is crucial. Intravesical bacillus Calmette‐Guerin (BCG) is the appropriate therapeutic strategy for patients with high‐grade urothelial carcinoma (HGCU)… read more here.
Keywords: paris system; cytology patients; calmette guerin; bacillus calmette ... See more keywords
Idiopathic granulomatous mastitis in a male breast following intravesical Bacille Calmette-Guerin treatment.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of infection and public health"
DOI: 10.1016/j.jiph.2019.09.006
Abstract: Idiopathic granulomatous mastitis (IGM) is a benign chronic inflammatory disorder of the breast tissue, with unknown etiology. IGM is extremely rare among male gender. In this case report, we present a male patient with superficial… read more here.
Keywords: following intravesical; breast; granulomatous mastitis; idiopathic granulomatous ... See more keywords
Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer
Sign Up to like & getrecommendations! Published in 2019 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2019.1647714
Abstract: Abstract Bacillus Calmette-Guerin (BCG) is derived from attenuated Mycobacterium bovis. It is the most common intravesical immunotherapy for treating early stage bladder cancer. Pott’s disease is a form of mycobacterial infection that involves the vertebrae.… read more here.
Keywords: bladder cancer; mycobacterium bovis; bladder; bacillus calmette ... See more keywords
New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008757
Abstract: Rationale: Recently, drug-related myasthenia gravis (MG) has received attention, because the number of reported cases involving MG associated with immune checkpoint inhibitors, a new immunotherapy, is increasing. We present a case involving the new onset… read more here.
Keywords: bacillus calmette; calmette guerin; myasthenia gravis; new onset ... See more keywords
Acupoint injection of Bacillus Calmette–Guerin polysaccharide nucleic acid for patients with chronic urticaria
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000019924
Abstract: Abstract Background: To investigate the efficacy and safety of acupoint injection of Bacillus Calmette–Guerin polysaccharide nucleic acid (BCG-PSN) in the treatment of chronic urticaria (CU). Methods: The following databases will be searched from their inception:… read more here.
Keywords: acupoint injection; injection; calmette guerin; injection bacillus ... See more keywords
Efficacy and safety of Bacillus Calmette-Guerin for bladder cancer
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000021930
Abstract: Abstract Background: This study will systematically assess the efficacy and safety of Bacillus Calmette-Guerin (BCG) for patients with bladder cancer (BC). Methods: Literature searches will be performed in multiple electronic databases from inception to present:… read more here.
Keywords: efficacy safety; efficacy; calmette guerin; safety bacillus ... See more keywords
Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000000846
Abstract: PURPOSE OF REVIEW A number of promising therapies for Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer (NMIBC) are in the pipeline. In this review, we discuss the history of immunotherapy for the treatment of… read more here.
Keywords: bcg unresponsive; cancer; calmette guerin; guerin bcg ... See more keywords
The safety and efficacy of Bacillus Calmette‐Guerin intravesical therapy in kidney transplant recipients with superficial bladder cancer
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Transplantation"
DOI: 10.1111/ctr.14377
Abstract: Bladder cancer is frequently encountered in kidney-recipients and its treatment can be challenging. In fact, it is not known whether adjuvant intravesical Bacillus Calmette-Guerin (BCG) instillation may be as effective and safe as in non-immunosuppressed… read more here.
Keywords: bladder cancer; safety efficacy; bacillus calmette; calmette guerin ... See more keywords
Bacillus Calmette–Guerin vaccination and multiple sclerosis: A population‐based birth cohort study in Quebec, Canada
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15290
Abstract: The bacillus Calmette–Guerin (BCG) vaccine could reduce the incidence of multiple sclerosis (MS) through immunomodulation. Previous studies, presenting some limitations, reported no association. We re‐examined this association in a large cohort focusing on relapsing–remitting MS… read more here.
Keywords: calmette guerin; bacillus calmette; multiple sclerosis;
Effectiveness of the Moreau strain of Bacillus Calmette-Guerin (BCG) for nonmuscle invasive bladder cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.4539
Abstract: 4539Background: Intravesical instillation therapy of Bacillus Calmette-Guerin (BCG) for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) after complete transurethral resection ... read more here.
Keywords: bladder cancer; invasive bladder; guerin bcg; bacillus calmette ... See more keywords
Bacillus Calmette-Guerin immunotherapy-increasing dose as a means of improving therapy?
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/tcr.2017.01.25
Abstract: Bladder cancer is not life threatening but it is characterized by frequent recurrences which may progress to muscle invasive disease. The standard therapy for intermediate and high grade non muscle invasive bladder cancer is tumor… read more here.
Keywords: bcg immunotherapy; immunotherapy; bacillus calmette; calmette guerin ... See more keywords